PAPER Goggi JL, Qiu L, Liao MC, Khanapur S, Jiang L, Boominathan R, Hartimath SV, Cheng P, Yong FF, Soh V, Deng X, Lin YM, Haslop A, Tan PW, Zeng X, Lee JW, Zhang Z, Sadasivam P, Tan EK, Luthra SK, Shingleton WD, Oh SK, Zeng L, Robins EG
SEARCH RESULTS
5518 RESULTS
PAPER Palermo G, Tommasini L, Baldacci F, Del Prete E, Siciliano G, Ceravolo R
Impact of Coronavirus Disease 2019 Pandemic on Cognition in Parkinson's Disease.
Mov Disord. 2020 Oct;35(10):1717-1718. Epub 2020 Sep 8 PubMed: 32776602PAPER Niznik JD, Zhao X, Aspinall SL, Hanlon JT, Hanson LC, Nace D, Thorpe JM, Thorpe CT
Reply to: Acetylcholinesterase Inhibitors and Dementia: Over Both Sides of the Atlantic Ocean.
J Am Geriatr Soc. 2020 Oct;68(10):2412-2413. Epub 2020 Aug 10 PubMed: 32776517PAPER Braillon A
Acetylcholinesterase Inhibitors and Dementia: Over Both Sides of the Atlantic Ocean.
J Am Geriatr Soc. 2020 Oct;68(10):2411. Epub 2020 Aug 10 PubMed: 32776514PAPER Minikel EV, Zhao HT, Le J, O'Moore J, Pitstick R, Graffam S, Carlson GA, Kavanaugh MP, Kriz J, Kim JB, Ma J, Wille H, Aiken J, McKenzie D, Doh-Ura K, Beck M, O'Keefe R, Stathopoulos J, Caron T, Schreiber SL, Carroll JB, Kordasiewicz HB, Cabin DE, Vallabh SM
Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints.
Nucleic Acids Res. 2020 Nov 4;48(19):10615-10631. PubMed: 32776089PAPER Schilde LM, Steinbach S, Serschnitzki B, Maass F, Bähr M, Lingor P, Marcus K, May C
Human cerebrospinal fluid data for use as spectral library, for biomarker research.
Data Brief. 2020 Oct;32:106048. Epub 2020 Jul 19 PubMed: 32775566PAPER Heckmann JG, Vachalova I, Vynogradova I, Schwab S
Dressing Apraxia as Initial Manifestation of Creutzfeldt-Jakob Disease.
Tremor Other Hyperkinet Mov (N Y). 2020 Jul 7;10:14. PubMed: 32775028PAPER Ahnaou A, Rodriguez-Manrique D, Embrechts S, Biermans R, Manyakov NV, Youssef SA, Drinkenburg WH
Aging Alters Olfactory Bulb Network Oscillations and Connectivity: Relevance for Aging-Related Neurodegeneration Studies.
Neural Plast. 2020;2020:1703969. Epub 2020 May 2 PubMed: 32774353PAPER Chiappelli F
Towards Neuro-CoViD-19.
Bioinformation. 2020;16(4):288-292. Epub 2020 Apr 30 PubMed: 32773986PAPER Hasimoglu YG, Chen X, Bakshi R, Schwarzschild MA, Macklin EA
Does Serum Urate Change as Parkinson's Disease Progresses?
J Parkinsons Dis. 2020;10(4):1571-1576. PubMed: 32773396PAPER Cignarella F, Filipello F, Bollman B, Cantoni C, Locca A, Mikesell R, Manis M, Ibrahim A, Deng L, Benitez BA, Cruchaga C, Licastro D, Mihindukulasuriya K, Harari O, Buckland M, Holtzman DM, Rosenthal A, Schwabe T, Tassi I, Piccio L
TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis.
Acta Neuropathol. 2020 Oct;140(4):513-534. Epub 2020 Aug 9 PubMed: 32772264PAPER Fattah A, Amiri F, Mohammadian M, Alipourfard I, Valilo M, Taheraghdam A, Hemmati-Dinarvand M
Dysregulation of body antioxidant content is related to initiation and progression of Parkinson's disease.
Neurosci Lett. 2020 Sep 25;736:135297. Epub 2020 Aug 7 PubMed: 32771603PAPER Brito DV, Della Coletta MV, Takano SA, Ferreira GB, Fantin C
Genetic analysis of Huntington's disease in a population from the Brazilian Amazon.
Parkinsonism Relat Disord. 2020 Sep;78:94-95. Epub 2020 Jul 16 PubMed: 32771600PAPER MacGregor Sharp M, Saito S, Keable A, Gatherer M, Aldea R, Agarwal N, Simpson JE, Wharton SB, Weller RO, Carare RO
Demonstrating a reduced capacity for removal of fluid from cerebral white matter and hypoxia in areas of white matter hyperintensity associated with age and dementia.
Acta Neuropathol Commun. 2020 Aug 8;8(1):131. PubMed: 32771063PAPER Liu L, Killoy KM, Vargas MR, Yamamoto Y, Pehar M
Effects of RAGE inhibition on the progression of the disease in hSOD1G93A ALS mice.
Pharmacol Res Perspect. 2020 Aug;8(4):e00636. PubMed: 32776498Current Filters
- Date Range : May 2020 to Aug 2020 x